Key Event Details
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has incorporated a wholly owned subsidiary company named "Alivus Life Sciences Do Brasil Ltda." in the State of Sao Paulo, Brazil. The incorporation was completed on September 15, 2026, at 18:50 Brazil Time.
Subsidiary Information
- Name: Alivus Life Sciences Do Brasil Ltda.
- Country of Incorporation: Brazil
- Authorized Capital: R$ 500,000.00 (five hundred thousand reais), divided into 500,000 (five hundred thousand shares)
- Industry: Pharmaceuticals
- Date of Incorporation: September 15, 2026
Financial Details
- The Company will subscribe to 100% of the paid-up share capital of the subsidiary
- Investment amount: Not exceeding R$ 500,000.00 (five hundred thousand reais)
- Consideration: Cash
- Turnover/Size: Not applicable as it is a newly incorporated company
Transaction Details
- This initial subscription does not fall within the purview of Related Party Transaction
- Promoter/promoter group/group companies of Alivus Life Sciences Limited do not have any interest in the subsidiary
- Time period for completion: Not applicable
- Objects and impact: Not applicable as this is for incorporation of a wholly owned subsidiary